Penn State U COM RGB 2C current research text box

Elfar.John edited

Principle Investigators: Dr. John Elfar

Disease: Traumatic limb injury

Research Description: When a limb injury is severe enough to cause paralysis, there are no relevant tests that can tell if a nerve is severed or not. Severed nerves require urgent surgery whereas non-severed nerves are best left to recover without surgery. Without a usable test of the status of the nerve, surgeons guess at the answer to this critical question. Dr. Elfar and his team discovered that a drug used to treat multiple sclerosis patients, 4-aminopyridine (4AP), has the property of awakening intact but paralyzed nerves. They will conduct a small, proof-of-concept clinical trial to test if the drug can be repurposed as a single-dose test for severed nerves in trauma patients. If successful, this pilot trial could lead to a desperately needed diagnostic to help providers distinguish between permanent and recoverable nerve injuries in every trauma patient, right away.

CWR Funding Role: Primary funder

CWR Funding Partner: Goldman Philanthropic Partnerships, the Kahlert Foundation

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Sunday the 29th. Copyright 2018 Cures Within Reach.